Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)

被引：0
|
作者：
Rezaie, Ali [1 ]
Heimanson, Zeev [2 ]
Israel, Robert J. [2 ]
McCallum, Richard [3 ]
Pimentel, Mark [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Salix Pharmaceut, Bridgewater, NJ USA
[3] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
468
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 50 条
  • [41] Intestinal symptoms and psychological status determined the quality of life for patients with Irritable Bowel Syndrome with Diarrhea (IBS-D)
    Zhu, L.
    Huang, D.
    Fang, X.
    Chang, M.
    Chen, W.
    Xin, H.
    Shi, L.
    Xu, T.
    Ke, M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 178 - 178
  • [42] Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
    Lembo, Anthony
    Rao, Satish S. C.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00144
  • [43] Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
    Breslin, Henry J.
    Diamond, Craig J.
    Kavash, Robert W.
    Cai, Chaozhong
    Dyatkin, Alexey B.
    Miskowski, Tamara A.
    Zhang, Sui-Po
    Wade, Paul R.
    Hornby, Pamela J.
    He, Wei
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4869 - 4872
  • [44] Cilansetron in irritable bowel syndrome with diarrhea predominance (IBS-D): Efficacy and safety in a 3 month US study
    Miner, P
    Stanton, DB
    Carter, F
    Caras, S
    Krause, G
    Steinborn, C
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S277 - S277
  • [45] Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?
    Xu, Xiao-juan
    Liu, Liang
    Yao, Shu-kun
    [J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2016, 17 (01): : 1 - 9
  • [46] Psychosocial determinants of rifaximin adherence for the treatment of diarrhea-predominant irritable bowel syndrome (IBS)
    Sherwin, L.
    Krisanabud, P.
    Deroche, C.
    Matteson-Kome, M.
    Ruppar, T.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [47] Cilansetron improves health related quality of life in patients with irritable bowel syndrome with diarrhea predominance (IBS-D)
    Olden, KW
    Drossman, DA
    Carter, F
    Caras, S
    Krause, G
    Steinborn, C
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S277 - S277
  • [48] Lactulose hydrogen breath test in the diagnosis of irritable bowel syndrome (IBS) caused by food intolerance
    Sen, S
    Dear, KLE
    King, TS
    Elia, M
    Hunter, JO
    [J]. GUT, 2001, 48 : A57 - A58
  • [49] Characterizing Diarrhea in Irritable Bowel Syndrome (IBS)
    Palsson, Olafur S.
    Turner, Marsha J.
    Baggish, Jeffrey S.
    Whitehead, William E.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A376 - A376
  • [50] Lactulose Breath Test Gas Production and Clinical Correlation in Childhood Irritable Bowel Syndrome (IBS)
    Chumpitazi, Bruno P.
    Weidler, Erica M.
    Shulman, Robert
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S745 - S745
12345